A new clinical trial in the United States allows couples to pick the sex of their unborn children in an effort to determine the social effects. The doctors create embryos for the study members using assisted reproduction. Then they figure out each embryo’s sex using a process called preimplantation genetic diagnosis (PGD). The parents then select a male or female embryo to be implanted in the mother’s uterus. The process is not new. PGD is also used to screen for genetic defects. And in about 3 percent of the thousands of PGD procedures conducted in the United States each year, parents are picking the gender of their babies, according to one study. Scientists have for years been debating the ethics and possible health, social and psychological effects of selecting for sex. The new clinical trial, reported today by the journal Nature, is designed to determine the impact of sexual selection. Researchers will study the physical health of the babies and social impact in the families over time. Sexual selection is banned in Britain, Canada and several other countries, according to the journal, at least in part because of public concerns that it would lead to sex discrimination.Researchers spent nine years getting permission to do the clinical trial, which began last month in Houston. Fifty couples have applied. The researchers will chose only those couples who have a child and want another of the opposite sex, according to Nature. The American Society for Reproductive Medicine and the American College of Obstetricians and Gynecologists oppose sexual selection.
